Kim Smith-Whitley

Chief Tech/Sci/R&D Officer en GLOBAL BLOOD THERAPEUTICS, INC. .

63 años

Consumer Services

Health Technology

Perfil

Kim Smith-Whitley is currently the Director at the Sickle Cell Disease Association of America, Inc. and the Executive VP, Head-Research & Development at Global Blood Therapeutics, Inc. Dr. Smith-Whitley holds a doctorate degree from George Washington University.

Cargos activos de Kim Smith-Whitley

Empresas	Cargo	Inicio
GLOBAL BLOOD THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	01/05/2021
Sickle Cell Disease Association of America, Inc.	Director/Board Member	-

Todos los cargos activos de Kim Smith-Whitley

Formación de Kim Smith-Whitley.

George Washington University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Kim Smith-Whitley.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Sickle Cell Disease Association of America, Inc.
Global Blood Therapeutics, Inc. Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA.	Health Technology